Table 3.

Logistic regression analysis to identify possible association between combined ICP/PbtO₂ guided therapy and 6-month unfavorable neurologic outcome in patients undergoing ICP- or ICP/PbtO₂ guided-therapy (n = 102).

	Univariable analysis OR (95% CI)	p-value	Multivariable analysis OR (95% CI)	p-value
ICP/PbtO2 guided therapy	0.29 (0.11–0.77)	0.02	0.33 (0.12–0.89)	0.02
Nimodipine prophylaxis	0.14 (0.02–1.23)	0.07	0.23 (0.03–1.98)	0.12
Endovascular therapy	0.29 (0.09–0.93)	0.04	0.47 (0.15–1.49)	0.19

Data are reported as odds ratio (OR) and 95% confidence intervals (CIs).

ICP intracranial hypertension, PbtO₂ brain tissue oxygenation.